img

Global Human Albumin Injection Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Albumin Injection Market Insights, Forecast to 2034

Human albumin solutions are used in a range of medical and surgical problems.
Global Human Albumin Injection market is expected to reach to US$ 410 million in 2024, with a positive growth of %, compared with US$ 396 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Human Albumin Injection industry is evaluated to reach US$ 549.4 million in 2029. The CAGR will be 5.0% during 2024 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Human Albumin Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Human Albumin Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Octapharma
CSL Behring
Biotest (UK) Ltd
Baxter
Kedrion Biopharma, Inc.
Grifols
GE HealthCare
Bio Products Laboratory
Green Cross
SK Plasma
Instituto Grifols
Takeda
Hualan Bio
Nanyue Biopharmaceuticals
Segment by Type
Blood Extraction
Recombine

Segment by Application


Hospital
Clinic

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Human Albumin Injection plant distribution, commercial date of Human Albumin Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Human Albumin Injection introduction, etc. Human Albumin Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Human Albumin Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Human Albumin Injection Product Introduction
1.2 Market by Type
1.2.1 Global Human Albumin Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Blood Extraction
1.2.3 Recombine
1.3 Market by Application
1.3.1 Global Human Albumin Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Albumin Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Human Albumin Injection Revenue by Region
2.2.1 Global Human Albumin Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Human Albumin Injection Revenue by Region (2018-2024)
2.2.3 Global Human Albumin Injection Revenue by Region (2024-2029)
2.2.4 Global Human Albumin Injection Revenue Market Share by Region (2018-2029)
2.3 Global Human Albumin Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Human Albumin Injection Sales by Region
2.4.1 Global Human Albumin Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Human Albumin Injection Sales by Region (2018-2024)
2.4.3 Global Human Albumin Injection Sales by Region (2024-2029)
2.4.4 Global Human Albumin Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Human Albumin Injection Sales by Manufacturers
3.1.1 Global Human Albumin Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Human Albumin Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Albumin Injection in 2022
3.2 Global Human Albumin Injection Revenue by Manufacturers
3.2.1 Global Human Albumin Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Human Albumin Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Albumin Injection Revenue in 2022
3.3 Global Key Players of Human Albumin Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Human Albumin Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Albumin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Albumin Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Albumin Injection, Product Offered and Application
3.8 Global Key Manufacturers of Human Albumin Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Albumin Injection Sales by Type
4.1.1 Global Human Albumin Injection Historical Sales by Type (2018-2024)
4.1.2 Global Human Albumin Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Human Albumin Injection Sales Market Share by Type (2018-2029)
4.2 Global Human Albumin Injection Revenue by Type
4.2.1 Global Human Albumin Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Human Albumin Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Human Albumin Injection Revenue Market Share by Type (2018-2029)
4.3 Global Human Albumin Injection Price by Type
4.3.1 Global Human Albumin Injection Price by Type (2018-2024)
4.3.2 Global Human Albumin Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Human Albumin Injection Sales by Application
5.1.1 Global Human Albumin Injection Historical Sales by Application (2018-2024)
5.1.2 Global Human Albumin Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Human Albumin Injection Sales Market Share by Application (2018-2029)
5.2 Global Human Albumin Injection Revenue by Application
5.2.1 Global Human Albumin Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Human Albumin Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Human Albumin Injection Revenue Market Share by Application (2018-2029)
5.3 Global Human Albumin Injection Price by Application
5.3.1 Global Human Albumin Injection Price by Application (2018-2024)
5.3.2 Global Human Albumin Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Human Albumin Injection Market Size by Type
6.1.1 US & Canada Human Albumin Injection Sales by Type (2018-2029)
6.1.2 US & Canada Human Albumin Injection Revenue by Type (2018-2029)
6.2 US & Canada Human Albumin Injection Market Size by Application
6.2.1 US & Canada Human Albumin Injection Sales by Application (2018-2029)
6.2.2 US & Canada Human Albumin Injection Revenue by Application (2018-2029)
6.3 US & Canada Human Albumin Injection Market Size by Country
6.3.1 US & Canada Human Albumin Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Human Albumin Injection Sales by Country (2018-2029)
6.3.3 US & Canada Human Albumin Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Albumin Injection Market Size by Type
7.1.1 Europe Human Albumin Injection Sales by Type (2018-2029)
7.1.2 Europe Human Albumin Injection Revenue by Type (2018-2029)
7.2 Europe Human Albumin Injection Market Size by Application
7.2.1 Europe Human Albumin Injection Sales by Application (2018-2029)
7.2.2 Europe Human Albumin Injection Revenue by Application (2018-2029)
7.3 Europe Human Albumin Injection Market Size by Country
7.3.1 Europe Human Albumin Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Human Albumin Injection Sales by Country (2018-2029)
7.3.3 Europe Human Albumin Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Albumin Injection Market Size
8.1.1 China Human Albumin Injection Sales (2018-2029)
8.1.2 China Human Albumin Injection Revenue (2018-2029)
8.2 China Human Albumin Injection Market Size by Application
8.2.1 China Human Albumin Injection Sales by Application (2018-2029)
8.2.2 China Human Albumin Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Human Albumin Injection Market Size by Type
9.1.1 Asia Human Albumin Injection Sales by Type (2018-2029)
9.1.2 Asia Human Albumin Injection Revenue by Type (2018-2029)
9.2 Asia Human Albumin Injection Market Size by Application
9.2.1 Asia Human Albumin Injection Sales by Application (2018-2029)
9.2.2 Asia Human Albumin Injection Revenue by Application (2018-2029)
9.3 Asia Human Albumin Injection Sales by Region
9.3.1 Asia Human Albumin Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Human Albumin Injection Revenue by Region (2018-2029)
9.3.3 Asia Human Albumin Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Albumin Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Albumin Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Human Albumin Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Human Albumin Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Albumin Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Human Albumin Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Human Albumin Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Human Albumin Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Human Albumin Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Human Albumin Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Octapharma
11.1.1 Octapharma Company Information
11.1.2 Octapharma Overview
11.1.3 Octapharma Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Octapharma Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Octapharma Recent Developments
11.2 CSL Behring
11.2.1 CSL Behring Company Information
11.2.2 CSL Behring Overview
11.2.3 CSL Behring Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSL Behring Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Behring Recent Developments
11.3 Biotest (UK) Ltd
11.3.1 Biotest (UK) Ltd Company Information
11.3.2 Biotest (UK) Ltd Overview
11.3.3 Biotest (UK) Ltd Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Biotest (UK) Ltd Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biotest (UK) Ltd Recent Developments
11.4 Baxter
11.4.1 Baxter Company Information
11.4.2 Baxter Overview
11.4.3 Baxter Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Baxter Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter Recent Developments
11.5 Kedrion Biopharma, Inc.
11.5.1 Kedrion Biopharma, Inc. Company Information
11.5.2 Kedrion Biopharma, Inc. Overview
11.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Kedrion Biopharma, Inc. Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kedrion Biopharma, Inc. Recent Developments
11.6 Grifols
11.6.1 Grifols Company Information
11.6.2 Grifols Overview
11.6.3 Grifols Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Grifols Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Grifols Recent Developments
11.7 GE HealthCare
11.7.1 GE HealthCare Company Information
11.7.2 GE HealthCare Overview
11.7.3 GE HealthCare Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 GE HealthCare Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GE HealthCare Recent Developments
11.8 Bio Products Laboratory
11.8.1 Bio Products Laboratory Company Information
11.8.2 Bio Products Laboratory Overview
11.8.3 Bio Products Laboratory Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bio Products Laboratory Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio Products Laboratory Recent Developments
11.9 Green Cross
11.9.1 Green Cross Company Information
11.9.2 Green Cross Overview
11.9.3 Green Cross Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Green Cross Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Green Cross Recent Developments
11.10 SK Plasma
11.10.1 SK Plasma Company Information
11.10.2 SK Plasma Overview
11.10.3 SK Plasma Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 SK Plasma Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 SK Plasma Recent Developments
11.11 Instituto Grifols
11.11.1 Instituto Grifols Company Information
11.11.2 Instituto Grifols Overview
11.11.3 Instituto Grifols Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Instituto Grifols Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Instituto Grifols Recent Developments
11.12 Takeda
11.12.1 Takeda Company Information
11.12.2 Takeda Overview
11.12.3 Takeda Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Takeda Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Takeda Recent Developments
11.13 Hualan Bio
11.13.1 Hualan Bio Company Information
11.13.2 Hualan Bio Overview
11.13.3 Hualan Bio Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Hualan Bio Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hualan Bio Recent Developments
11.14 Nanyue Biopharmaceuticals
11.14.1 Nanyue Biopharmaceuticals Company Information
11.14.2 Nanyue Biopharmaceuticals Overview
11.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Nanyue Biopharmaceuticals Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Nanyue Biopharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Albumin Injection Industry Chain Analysis
12.2 Human Albumin Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Albumin Injection Production Mode & Process
12.4 Human Albumin Injection Sales and Marketing
12.4.1 Human Albumin Injection Sales Channels
12.4.2 Human Albumin Injection Distributors
12.5 Human Albumin Injection Customers
13 Market Dynamics
13.1 Human Albumin Injection Industry Trends
13.2 Human Albumin Injection Market Drivers
13.3 Human Albumin Injection Market Challenges
13.4 Human Albumin Injection Market Restraints
14 Key Findings in The Global Human Albumin Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Albumin Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Blood Extraction
Table 3. Major Manufacturers of Recombine
Table 4. Global Human Albumin Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Human Albumin Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Human Albumin Injection Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Human Albumin Injection Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Human Albumin Injection Revenue Market Share by Region (2018-2024)
Table 9. Global Human Albumin Injection Revenue Market Share by Region (2024-2029)
Table 10. Global Human Albumin Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Human Albumin Injection Sales by Region (2018-2024) & (K Units)
Table 12. Global Human Albumin Injection Sales by Region (2024-2029) & (K Units)
Table 13. Global Human Albumin Injection Sales Market Share by Region (2018-2024)
Table 14. Global Human Albumin Injection Sales Market Share by Region (2024-2029)
Table 15. Global Human Albumin Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Human Albumin Injection Sales Share by Manufacturers (2018-2024)
Table 17. Global Human Albumin Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Human Albumin Injection Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Human Albumin Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Human Albumin Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Human Albumin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Human Albumin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Albumin Injection as of 2022)
Table 23. Global Key Manufacturers of Human Albumin Injection, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Human Albumin Injection, Product Offered and Application
Table 25. Global Key Manufacturers of Human Albumin Injection, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Albumin Injection Sales by Type (2018-2024) & (K Units)
Table 28. Global Human Albumin Injection Sales by Type (2024-2029) & (K Units)
Table 29. Global Human Albumin Injection Sales Share by Type (2018-2024)
Table 30. Global Human Albumin Injection Sales Share by Type (2024-2029)
Table 31. Global Human Albumin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Human Albumin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Human Albumin Injection Revenue Share by Type (2018-2024)
Table 34. Global Human Albumin Injection Revenue Share by Type (2024-2029)
Table 35. Human Albumin Injection Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Human Albumin Injection Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Human Albumin Injection Sales by Application (2018-2024) & (K Units)
Table 38. Global Human Albumin Injection Sales by Application (2024-2029) & (K Units)
Table 39. Global Human Albumin Injection Sales Share by Application (2018-2024)
Table 40. Global Human Albumin Injection Sales Share by Application (2024-2029)
Table 41. Global Human Albumin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Human Albumin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Human Albumin Injection Revenue Share by Application (2018-2024)
Table 44. Global Human Albumin Injection Revenue Share by Application (2024-2029)
Table 45. Human Albumin Injection Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Human Albumin Injection Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Human Albumin Injection Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Human Albumin Injection Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Human Albumin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Human Albumin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Human Albumin Injection Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Human Albumin Injection Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Human Albumin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Human Albumin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Human Albumin Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Human Albumin Injection Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Human Albumin Injection Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Human Albumin Injection Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Human Albumin Injection Sales by Country (2024-2029) & (K Units)
Table 60. Europe Human Albumin Injection Sales by Type (2018-2024) & (K Units)
Table 61. Europe Human Albumin Injection Sales by Type (2024-2029) & (K Units)
Table 62. Europe Human Albumin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Human Albumin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Human Albumin Injection Sales by Application (2018-2024) & (K Units)
Table 65. Europe Human Albumin Injection Sales by Application (2024-2029) & (K Units)
Table 66. Europe Human Albumin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Human Albumin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Human Albumin Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Human Albumin Injection Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Human Albumin Injection Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Human Albumin Injection Sales by Country (2018-2024) & (K Units)
Table 72. Europe Human Albumin Injection Sales by Country (2024-2029) & (K Units)
Table 73. China Human Albumin Injection Sales by Type (2018-2024) & (K Units)
Table 74. China Human Albumin Injection Sales by Type (2024-2029) & (K Units)
Table 75. China Human Albumin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Human Albumin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Human Albumin Injection Sales by Application (2018-2024) & (K Units)
Table 78. China Human Albumin Injection Sales by Application (2024-2029) & (K Units)
Table 79. China Human Albumin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Human Albumin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Human Albumin Injection Sales by Type (2018-2024) & (K Units)
Table 82. Asia Human Albumin Injection Sales by Type (2024-2029) & (K Units)
Table 83. Asia Human Albumin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Human Albumin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Human Albumin Injection Sales by Application (2018-2024) & (K Units)
Table 86. Asia Human Albumin Injection Sales by Application (2024-2029) & (K Units)
Table 87. Asia Human Albumin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Human Albumin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Human Albumin Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Human Albumin Injection Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Human Albumin Injection Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Human Albumin Injection Sales by Region (2018-2024) & (K Units)
Table 93. Asia Human Albumin Injection Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Human Albumin Injection Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Human Albumin Injection Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Human Albumin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Human Albumin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Human Albumin Injection Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Human Albumin Injection Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Human Albumin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Human Albumin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Human Albumin Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Human Albumin Injection Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Albumin Injection Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Human Albumin Injection Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Human Albumin Injection Sales by Country (2024-2029) & (K Units)
Table 107. Octapharma Company Information
Table 108. Octapharma Description and Major Businesses
Table 109. Octapharma Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Octapharma Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Octapharma Recent Developments
Table 112. CSL Behring Company Information
Table 113. CSL Behring Description and Major Businesses
Table 114. CSL Behring Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. CSL Behring Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSL Behring Recent Developments
Table 117. Biotest (UK) Ltd Company Information
Table 118. Biotest (UK) Ltd Description and Major Businesses
Table 119. Biotest (UK) Ltd Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Biotest (UK) Ltd Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Biotest (UK) Ltd Recent Developments
Table 122. Baxter Company Information
Table 123. Baxter Description and Major Businesses
Table 124. Baxter Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Baxter Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Baxter Recent Developments
Table 127. Kedrion Biopharma, Inc. Company Information
Table 128. Kedrion Biopharma, Inc. Description and Major Businesses
Table 129. Kedrion Biopharma, Inc. Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Kedrion Biopharma, Inc. Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Kedrion Biopharma, Inc. Recent Developments
Table 132. Grifols Company Information
Table 133. Grifols Description and Major Businesses
Table 134. Grifols Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Grifols Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Grifols Recent Developments
Table 137. GE HealthCare Company Information
Table 138. GE HealthCare Description and Major Businesses
Table 139. GE HealthCare Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. GE HealthCare Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. GE HealthCare Recent Developments
Table 142. Bio Products Laboratory Company Information
Table 143. Bio Products Laboratory Description and Major Businesses
Table 144. Bio Products Laboratory Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Bio Products Laboratory Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bio Products Laboratory Recent Developments
Table 147. Green Cross Company Information
Table 148. Green Cross Description and Major Businesses
Table 149. Green Cross Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Green Cross Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Green Cross Recent Developments
Table 152. SK Plasma Company Information
Table 153. SK Plasma Description and Major Businesses
Table 154. SK Plasma Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. SK Plasma Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. SK Plasma Recent Developments
Table 157. Instituto Grifols Company Information
Table 158. Instituto Grifols Description and Major Businesses
Table 159. Instituto Grifols Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Instituto Grifols Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Instituto Grifols Recent Developments
Table 162. Takeda Company Information
Table 163. Takeda Description and Major Businesses
Table 164. Takeda Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Takeda Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Takeda Recent Developments
Table 167. Hualan Bio Company Information
Table 168. Hualan Bio Description and Major Businesses
Table 169. Hualan Bio Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Hualan Bio Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Hualan Bio Recent Developments
Table 172. Nanyue Biopharmaceuticals Company Information
Table 173. Nanyue Biopharmaceuticals Description and Major Businesses
Table 174. Nanyue Biopharmaceuticals Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Nanyue Biopharmaceuticals Human Albumin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Nanyue Biopharmaceuticals Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Human Albumin Injection Distributors List
Table 180. Human Albumin Injection Customers List
Table 181. Human Albumin Injection Market Trends
Table 182. Human Albumin Injection Market Drivers
Table 183. Human Albumin Injection Market Challenges
Table 184. Human Albumin Injection Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Albumin Injection Product Picture
Figure 2. Global Human Albumin Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Albumin Injection Market Share by Type in 2022 & 2029
Figure 4. Blood Extraction Product Picture
Figure 5. Recombine Product Picture
Figure 6. Global Human Albumin Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Human Albumin Injection Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Human Albumin Injection Report Years Considered
Figure 11. Global Human Albumin Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Human Albumin Injection Revenue 2018-2029 (US$ Million)
Figure 13. Global Human Albumin Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Human Albumin Injection Revenue Market Share by Region (2018-2029)
Figure 15. Global Human Albumin Injection Sales 2018-2029 ((K Units)
Figure 16. Global Human Albumin Injection Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Human Albumin Injection Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Human Albumin Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Human Albumin Injection Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Human Albumin Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Human Albumin Injection Sales YoY (2018-2029) & (K Units)
Figure 22. China Human Albumin Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Human Albumin Injection Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Human Albumin Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Human Albumin Injection Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Human Albumin Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Human Albumin Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Human Albumin Injection in the World: Market Share by Human Albumin Injection Revenue in 2022
Figure 29. Global Human Albumin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Human Albumin Injection Sales Market Share by Type (2018-2029)
Figure 31. Global Human Albumin Injection Revenue Market Share by Type (2018-2029)
Figure 32. Global Human Albumin Injection Sales Market Share by Application (2018-2029)
Figure 33. Global Human Albumin Injection Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Human Albumin Injection Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Human Albumin Injection Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Human Albumin Injection Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Human Albumin Injection Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Human Albumin Injection Revenue Share by Country (2018-2029)
Figure 39. US & Canada Human Albumin Injection Sales Share by Country (2018-2029)
Figure 40. U.S. Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Human Albumin Injection Sales Market Share by Type (2018-2029)
Figure 43. Europe Human Albumin Injection Revenue Market Share by Type (2018-2029)
Figure 44. Europe Human Albumin Injection Sales Market Share by Application (2018-2029)
Figure 45. Europe Human Albumin Injection Revenue Market Share by Application (2018-2029)
Figure 46. Europe Human Albumin Injection Revenue Share by Country (2018-2029)
Figure 47. Europe Human Albumin Injection Sales Share by Country (2018-2029)
Figure 48. Germany Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 49. France Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 53. China Human Albumin Injection Sales Market Share by Type (2018-2029)
Figure 54. China Human Albumin Injection Revenue Market Share by Type (2018-2029)
Figure 55. China Human Albumin Injection Sales Market Share by Application (2018-2029)
Figure 56. China Human Albumin Injection Revenue Market Share by Application (2018-2029)
Figure 57. Asia Human Albumin Injection Sales Market Share by Type (2018-2029)
Figure 58. Asia Human Albumin Injection Revenue Market Share by Type (2018-2029)
Figure 59. Asia Human Albumin Injection Sales Market Share by Application (2018-2029)
Figure 60. Asia Human Albumin Injection Revenue Market Share by Application (2018-2029)
Figure 61. Asia Human Albumin Injection Revenue Share by Region (2018-2029)
Figure 62. Asia Human Albumin Injection Sales Share by Region (2018-2029)
Figure 63. Japan Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 67. India Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Human Albumin Injection Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Human Albumin Injection Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Human Albumin Injection Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Human Albumin Injection Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Human Albumin Injection Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Human Albumin Injection Sales Share by Country (2018-2029)
Figure 74. Brazil Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Human Albumin Injection Revenue (2018-2029) & (US$ Million)
Figure 79. Human Albumin Injection Value Chain
Figure 80. Human Albumin Injection Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed